Total synthesis and comparative evaluation of luzopeptin A-C and quinoxapeptin A-C

Journal of the American Chemical Society

Volumn 121, Issue 49, 1999, Pages 11375-11383

  Boger, Dale L ^a   Ledeboer, Mark W ^a   Kume, Masaharu ^a   Searcey, Mark ^a   Jin, Qing ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUZOPEPTIN A; QUINOXALINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE;

ACYLATION; ARTICLE; CHEMICAL ANALYSIS; CYCLIZATION; CYTOTOXICITY; DNA BINDING; ENZYME INHIBITION; SYNTHESIS;

EID: 0033572757     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja993019e     Document Type: Article

References (59)

1. Toda, S.; Sugawara, K.; Nishiyama, Y.; Ohbayashi, M.; Ohkusa, N.; Yamamoto, H.; Konishi, M.; Oki, T. J. Antibiot. 1990, 43, 796.
2. Matson, J. A.; Bush, J. A. J. Antibiot. 1989, 42, 1763. Matson, J. A.; Colson, K. L.; Belofsky, G. N.; Bleiberg, B. B. J. Antibiot. 1993, 46, 162.
3. Matson, J. A.; Bush, J. A. J. Antibiot. 1989, 42, 1763. Matson, J. A.; Colson, K. L.; Belofsky, G. N.; Bleiberg, B. B. J. Antibiot. 1993, 46, 162.
4. Total synthesis of sandramycin: Boger, D. L.; Chen, J.-H. J. Am. Chem. Soc. 1993, 115, 11624. Boger, D. L.; Chen, J.-H.; Saionz, K. W. J. Am. Chem. Soc. 1996, 118, 1629.
5. Total synthesis of sandramycin: Boger, D. L.; Chen, J.-H. J. Am. Chem. Soc. 1993, 115, 11624. Boger, D. L.; Chen, J.-H.; Saionz, K. W. J. Am. Chem. Soc. 1996, 118, 1629.
6. Boger, D. L.; Chen, J.-H.; Saionz, K. W.; Jin, Q. Bioorg. Med. Chem. 1998, 6, 85. Boger, D. L.; Saionz, K. W. Bioorg. Med. Chem. 1999, 7, 315.
7. Boger, D. L.; Chen, J.-H.; Saionz, K. W.; Jin, Q. Bioorg. Med. Chem. 1998, 6, 85. Boger, D. L.; Saionz, K. W. Bioorg. Med. Chem. 1999, 7, 315.
8. Konishi, M.; Ohkuma, H.; Sakai, F.; Tsuno, T.; Koshiyama, H.; Naito, T.; Kawaguchi, H. J. Antibiot. 1981, 34, 148. Ohkuma, H.; Sakai, F.; Nishiyama, Y.; Ohbayashi, M.; Imanishi, H.; Konishi, M.; Miyaki, T.; Koshiyama, H.; Kawaguchi, H. J. Antibiot. 1980, 33, 1087. Tomita, K.; Hoshino, Y.; Sasahira, T.; Kawaguchi, H. J. Antibiot. 1980, 33, 1098.
9. Konishi, M.; Ohkuma, H.; Sakai, F.; Tsuno, T.; Koshiyama, H.; Naito, T.; Kawaguchi, H. J. Antibiot. 1981, 34, 148. Ohkuma, H.; Sakai, F.; Nishiyama, Y.; Ohbayashi, M.; Imanishi, H.; Konishi, M.; Miyaki, T.; Koshiyama, H.; Kawaguchi, H. J. Antibiot. 1980, 33, 1087. Tomita, K.; Hoshino, Y.; Sasahira, T.; Kawaguchi, H. J. Antibiot. 1980, 33, 1098.
10. Konishi, M.; Ohkuma, H.; Sakai, F.; Tsuno, T.; Koshiyama, H.; Naito, T.; Kawaguchi, H. J. Antibiot. 1981, 34, 148. Ohkuma, H.; Sakai, F.; Nishiyama, Y.; Ohbayashi, M.; Imanishi, H.; Konishi, M.; Miyaki, T.; Koshiyama, H.; Kawaguchi, H. J. Antibiot. 1980, 33, 1087. Tomita, K.; Hoshino, Y.; Sasahira, T.; Kawaguchi, H. J. Antibiot. 1980, 33, 1098.
11. Arnold, E.; Clardy, J. J. Am. Chem. Soc. 1981, 103, 1243. Konishi, M.; Ohkuma, H.; Sakai, F.; Tsuno, T.; Koshiyama, H.; Naito, T.; Kawaguchi, H. J. Am. Chem. Soc. 1981, 103, 1241.
12. Arnold, E.; Clardy, J. J. Am. Chem. Soc. 1981, 103, 1243. Konishi, M.; Ohkuma, H.; Sakai, F.; Tsuno, T.; Koshiyama, H.; Naito, T.; Kawaguchi, H. J. Am. Chem. Soc. 1981, 103, 1241.
13. Luzopeptins A-C: Boger, D. L.; Ledeboer, M. W.; Kume, M. J. Am. Chem. Soc. 1999, 121, 1098. Quinoxapeptins A-C: Boger, D. L.; Ledeboer, M. W.; Kume, M.; Jin, Q. Angew. Chem., Int. Ed. 1999, 38, 2424.
14. Luzopeptins A-C: Boger, D. L.; Ledeboer, M. W.; Kume, M. J. Am. Chem. Soc. 1999, 121, 1098. Quinoxapeptins A-C: Boger, D. L.; Ledeboer, M. W.; Kume, M.; Jin, Q. Angew. Chem., Int. Ed. 1999, 38, 2424.
15. Huang, C.-H.; Mong, S.; Crooke, S. T. Biochemistry 1980, 19, 5537. Huang, C.-H.; Prestayko, A. W.; Crooke, S. T. Biochemistry 1982, 21, 3704. Huang, C.-H.; Mirabelli, C. K.; Mong, S.; Crooke, S. T. Cancer Res. 1983, 43, 2718. Huang, C.-H.; Crooke, S. T. Cancer Res. 1985, 45, 3768.
16. Huang, C.-H.; Mong, S.; Crooke, S. T. Biochemistry 1980, 19, 5537. Huang, C.-H.; Prestayko, A. W.; Crooke, S. T. Biochemistry 1982, 21, 3704. Huang, C.-H.; Mirabelli, C. K.; Mong, S.; Crooke, S. T. Cancer Res. 1983, 43, 2718. Huang, C.-H.; Crooke, S. T. Cancer Res. 1985, 45, 3768.
17. Huang, C.-H.; Mong, S.; Crooke, S. T. Biochemistry 1980, 19, 5537. Huang, C.-H.; Prestayko, A. W.; Crooke, S. T. Biochemistry 1982, 21, 3704. Huang, C.-H.; Mirabelli, C. K.; Mong, S.; Crooke, S. T. Cancer Res. 1983, 43, 2718. Huang, C.-H.; Crooke, S. T. Cancer Res. 1985, 45, 3768.
18. Huang, C.-H.; Mong, S.; Crooke, S. T. Biochemistry 1980, 19, 5537. Huang, C.-H.; Prestayko, A. W.; Crooke, S. T. Biochemistry 1982, 21, 3704. Huang, C.-H.; Mirabelli, C. K.; Mong, S.; Crooke, S. T. Cancer Res. 1983, 43, 2718. Huang, C.-H.; Crooke, S. T. Cancer Res. 1985, 45, 3768.
19. Rose, W. C.; Schurig, J. E.; Huftalen, J. B.; Bradner, W. T. Cancer Res. 1983, 43, 1504. Huang, C.-H.; Crooke, S. T. Anti-Cancer Drug Des. 1986, 1, 87.
20. Rose, W. C.; Schurig, J. E.; Huftalen, J. B.; Bradner, W. T. Cancer Res. 1983, 43, 1504. Huang, C.-H.; Crooke, S. T. Anti-Cancer Drug Des. 1986, 1, 87.
21. Boger, D. L.; Chen, J.-H. Bioorg. Med. Chem. Lett. 1997, 7, 919.
22. Take, Y.; Inouye, Y.; Nakamura, S.; Allaudeen, H. S.; Kubo, A. J. Antibiot. 1989, 42, 107. Inouye, Y.; Take, Y.; Nakamura, S.; Nakashima, H.; Yamamoto, N.; Kawaguchi, H. J. Antibiot. 1987, 40, 100.
23. Take, Y.; Inouye, Y.; Nakamura, S.; Allaudeen, H. S.; Kubo, A. J. Antibiot. 1989, 42, 107. Inouye, Y.; Take, Y.; Nakamura, S.; Nakashima, H.; Yamamoto, N.; Kawaguchi, H. J. Antibiot. 1987, 40, 100.
24. Lingham, R. B.; Hsu, A. H. M.; O'Brien, J. A.; Sigmund, J. M.; Sanchez, M.; Gagliardi, M. M.; Heimbuch, B. K.; Genilloud, O.; Martin, I.; Diez, M. T.; Hirsch, C. F.; Zink, D. L.; Liesch, J. M.; Koch, G. E.; Gartner, S. E.: Garrity, G. M.; Tsou, N. N.; Salituro, G. M. J. Antibiot. 1996, 49, 253.
25. Olsen, R. K.; Apparao, S.; Bhat, K. L. J. Org. Chem. 1986, 51, 3079.
26. Hughes, P.; Clardy, J. J. Org. Chem. 1989, 54, 3260. Greck, C.; Bischoff, L.; Genet. J. P. Tetrahedron: Asymmetry 1995, 6, 1989.
27. Hughes, P.; Clardy, J. J. Org. Chem. 1989, 54, 3260. Greck, C.; Bischoff, L.; Genet. J. P. Tetrahedron: Asymmetry 1995, 6, 1989.
28. Ciufolini, M. A.; Swaminathan, S. Tetrahedron Lett. 1989, 30, 3027. Ciufolini, M. A.; Xi, N. J. Chem. Soc., Chem. Commun. 1994, 1867. Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 1995, 36, 6595. Ciufolini, M.; Xi, N. J: Org. Chem. 1997, 62, 2320. Xi, N.: Alemany, L. B.; Ciufolini, M. A. J. Am. Chem. Soc. 1998, 120, 80.
29. Ciufolini, M. A.; Swaminathan, S. Tetrahedron Lett. 1989, 30, 3027. Ciufolini, M. A.; Xi, N. J. Chem. Soc., Chem. Commun. 1994, 1867. Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 1995, 36, 6595. Ciufolini, M.; Xi, N. J: Org. Chem. 1997, 62, 2320. Xi, N.: Alemany, L. B.; Ciufolini, M. A. J. Am. Chem. Soc. 1998, 120, 80.
30. Ciufolini, M. A.; Swaminathan, S. Tetrahedron Lett. 1989, 30, 3027. Ciufolini, M. A.; Xi, N. J. Chem. Soc., Chem. Commun. 1994, 1867. Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 1995, 36, 6595. Ciufolini, M.; Xi, N. J: Org. Chem. 1997, 62, 2320. Xi, N.: Alemany, L. B.; Ciufolini, M. A. J. Am. Chem. Soc. 1998, 120, 80.
31. Ciufolini, M. A.; Swaminathan, S. Tetrahedron Lett. 1989, 30, 3027. Ciufolini, M. A.; Xi, N. J. Chem. Soc., Chem. Commun. 1994, 1867. Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 1995, 36, 6595. Ciufolini, M.; Xi, N. J: Org. Chem. 1997, 62, 2320. Xi, N.: Alemany, L. B.; Ciufolini, M. A. J. Am. Chem. Soc. 1998, 120, 80.
32. Ciufolini, M. A.; Swaminathan, S. Tetrahedron Lett. 1989, 30, 3027. Ciufolini, M. A.; Xi, N. J. Chem. Soc., Chem. Commun. 1994, 1867. Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 1995, 36, 6595. Ciufolini, M.; Xi, N. J: Org. Chem. 1997, 62, 2320. Xi, N.: Alemany, L. B.; Ciufolini, M. A. J. Am. Chem. Soc. 1998, 120, 80.
33. Boger, D. L.; Schüle, G. J. Org. Chem. 1998, 63, 6421.
34. Fox, K. R.; Davies, H.; Adams, G. R.; Portugal, J.; Waring, M. J. Nucleic Acids Res. 1988, 16, 2489. Fox, K. R.; Woolley, C. Biochem. Pharmacol, 1990, 39, 941.
35. Fox, K. R.; Davies, H.; Adams, G. R.; Portugal, J.; Waring, M. J. Nucleic Acids Res. 1988, 16, 2489. Fox, K. R.; Woolley, C. Biochem. Pharmacol, 1990, 39, 941.
36. Searle, M. S.; Hall, J. G,; Wakelin, L. P. G. Biochem. J. 1988, 256, 271. Searle, M. S.; Hall, J. G.; Denny, W. A.; Wakelin, L. P. G. Biochem. J. 1989, 259, 433.
37. Searle, M. S.; Hall, J. G,; Wakelin, L. P. G. Biochem. J. 1988, 256, 271. Searle, M. S.; Hall, J. G.; Denny, W. A.; Wakelin, L. P. G. Biochem. J. 1989, 259, 433.
38. Zhang, X.; Patel, D. J. Biochemistry 1991, 30, 4026. Leroy, J. L.; Gao, X.; Misra, V.; Gueron, M.; Patel, D. J. Biochemistry 1992, 31, 1407.
39. Zhang, X.; Patel, D. J. Biochemistry 1991, 30, 4026. Leroy, J. L.; Gao, X.; Misra, V.; Gueron, M.; Patel, D. J. Biochemistry 1992, 31, 1407.
40. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765.
41. Roush, W. R.; Adam, M. A. J. Org. Chem. 1985, 50, 3752. The crystallinity of 11 provided the opportunity to ensure pure material free of the isomer 10 was utilized.
42. EDCI = 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; HOAt = 1-hydroxy-7-azabenzotriazole; DCC = 1,3-dicydohexylcarbodiimide; DMAP = 4-dimethylaminopyridine; HOBt = 1-hydoxybenzotriazole; SES = 2-(trimethylsilyl)ethylsulfonyl.
43. 15 and failed to provide 17 in our preliminary efforts.
44. Carpino, L. A.: Han, G. Y. J. Org. Chem. 1972, 22, 3404.
45. Hassner, A.; Alexanian, V. Tetrahedron Lett. 1978, 19, 4475.
46. Analysis of the starting ester revealed that 23 existed as a mixture (94:6) of enatiomers. The major (S)-enantiomer of 23 was chromatographically purified on a semipreparative Diacel Chiracel OD column (10 μm, 2 × 25 cm. 15% i-PrOH-hexane, 7.0 mL/min flow rate). The relative ratio of enatiomers was determined on an analytical Chiracel OD column (10 μm, 0.46 × 25 cm. 10% i-PrOH-hexane, 1.0 mL/min flow rate). The efluent was monitored at 235 nm, and the enantiomers eluted with a retention time of 9.98 (major S-23) and 11.48 min (minor R-23). respectively (α = 1.15).
47. The epimers of 20 were chromatographically separated, and their relative ratio was determined on a semipreparative Diacel Chiracel OD column (10 μm, 2 × 25 cm, 50% i-PrOH-hexane. 7.0 mL/min flow rate). The effluent was monitored at 265 nm, and the diastereomers eluted with a retention time of 26.3 (20) and 32.3 min (epi-20), respectively (α = 1.23).
48. Characterization of these three products may be found in the Supporting Information.
49. Anwer, M. K.; Spatola, A. F. Synthesis 1980, 929.
50. Weinreb, S. M.; Demko, D. M.: Lessen, T. A. Tetrahedron Lett. 1986, 27, 2099.
51. 2O 3/1/1, 23 °C, 10 h (70%).
52. Boger, D. L.; Chen, J.-H. J. Org. Chem. 1995, 60, 7369.
53. Altering the length of time exposed to the hydrolysis conditions alters the relative amounts of 1-3 obtained.
54. 3), limiting the possibilities to 1R,2R-34 or 1S,2S-34.
55. 3), limiting the possibilities to 1R,2R-34 or 1S,2S-34.
56. Dumaitre, B. A.: Dodic, N.; Daugan, A. C. M.; Pianetti, P. M. C. PCT Int. Appl. WO9401408; Chem. Abstr. 1995, 122, 31342e. A detailed procedure for the preparation of 33 is provided in the Supporting Information.
57. Dumaitre, B. A.: Dodic, N.; Daugan, A. C. M.; Pianetti, P. M. C. PCT Int. Appl. WO9401408; Chem. Abstr. 1995, 122, 31342e. A detailed procedure for the preparation of 33 is provided in the Supporting Information.
58. Feldman, H. A. Anal. Biochem. 1972, 48, 317.
59. Full characterization data are provided in the Supporting Information.